“…If CNTs are to reach their full potential for biotechnological applications (Bianco et al, 2005), new and scalable methods that allow for accurate cyto and genotoxicity evaluations need to be developed and implemented. Further, such methods should also allow for real-time assessment, minimum false positives, risk analysis of a variety of concentrations of nanomaterial being used for exposure, as well as risk correlations based on the nanomaterial length (Sato et al, 2005), diameter (Nagai et al, 2011), aggregation (Wick et al, 2007), impurities content (Aldieri et al, 2013), and/or surface chemistry (Saxena et al, 2007), just to name a few.…”